Pga S.p.a. opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Pga S.p.a.

Patent Number:
Title:
Dry Powder Inhaler With An Adherence/Compliance Monitor
Opposition Date:
May 22, 2024
Patent Number:
Title:
Pharmaceutical Composition Containing Glycopyrrolate And A Beta2 Adrenoceptor Agonist
Applicant:
Opposition Date:
Sep 10, 2020

Want to track Pga S.p.a.?

Feel free to send us a message here and we will get back to you